Nurix Therapeutics, With 345% Run, Posts A ‘Clear Win’ In Leukemia Treatment

Nurix posted a “clear win” in leukemia treatment on Monday, but the biotech stock gave back some of its gains.
The post Nurix Therapeutics, With 345% Run, Posts A 'Clear Win' In Leukemia Treatment appeared first on Investor's Business Da…